Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
January 2013 Volume 5 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January 2013 Volume 5 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Anti-inflammatory activity of Yanshu spraying agent in animal models

  • Authors:
    • Jianqiao Zhang
    • Hongsheng Wang
    • Tian Wang
    • Yating Chong
    • Pengfei Yu
    • Chengwen Lu
    • Yunli Xue
    • Fenghua Fu
    • Leiming Zhang
  • View Affiliations / Copyright

    Affiliations: Department of Pharmacology, School of Pharmacy, Yantai University, Yantai, Shandong 264005, P.R. China, Nanjing Luye Sike Pharmaceutical Co., Ltd, Nanjing, Jiangsu 210061, P.R. China
  • Pages: 73-76
    |
    Published online on: October 25, 2012
       https://doi.org/10.3892/etm.2012.761
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Acute pharyngitis is characterized by an inflammation of the mucous membranes in the pharynx. Yanshu spraying agent was prepared according to the traditional Chinese formulation for the treatment of acute pharyngitis. The present study aimed to investigate the anti-inflammatory effect of Yanshu in xylene-induced ear edema in mice and carrageenan‑induced paw edema in rats by measuring the degree of edema in the animal models. The histopathology and the levels of prostaglandin E2 (PGE2) and cycloxygenase-2 (COX-2) in the hind paws of the carrageenan-treated rats were also analyzed. The results showed that Yanshu significantly reduced ear edema in the mice and paw edema in the rats. Furthermore, treatment with Yanshu also reduced the number of inflammatory cells in tissue and decreased the production of PGE2 and COX-2. These results suggest that Yanshu possesses potent anti‑inflammatory activity mediated by the inhibition of COX-2 expression which, in turn, downregulates the inflammatory mediator PGE2.

Introduction

Acute pharyngitis, an acute inflammation of the pharyngeal mucous membrane, is often caused by upper respiratory tract infection with a virus or bacteria. Its clinical manifestations include soreness of the throat, cough, pain on swallowing and fever (1).

The most common causes of acute pharyngitis are viral infections (2). Normally, the illness is mild and self-limiting but it may worsen due to bacterial superinfection, most commonly by group A or C β-hemolytic streptococci. Serious sequelae, including rheumatic fever and endocarditis, may follow bacterial superinfection (1). Due to the predominantly viral cause, antibiotics have only a minor benefit upon the resolution of pharyngitis symptoms. Thus, in most cases the treatment of acute pharyngitis is symptomatic, focusing on the management of symptoms such as fever, pain and inflammation.

Previous treatments of acute pharyngitis with fever, pain or inflammation include non-steroidal anti-inflammatory drugs and steroids (3,4), which have potential risks and side-effects (5). Chinese traditional medicine has been used to treat pharyngitis for a number of years (6,7). The treatment principle for this disease depends upon its symptoms or cause. Anti-inflammatory, antiviral and fever relieving herbs are the basic elements of the prescription.

Yanshu spraying agent, a potential drug for pharyngitis, consists of eleven herbs, including Radix Sophorae Tonkinensis, Calyx seu Fructus Physalis Francheti and Radix Scutellariae Baicalensis. However, its pharmacological effects have not been demonstrated. The aim of this study was to investigate the anti-inflammatory effects of Yanshu in the treatment of xylene- and carrageenan-induced acute inflammation in animals.

Materials and methods

Drugs and chemicals

Yanshu was provided by Shandong Luye Pharmaceutical Co., Ltd. (Yantai, China; batch no. 20110810). It is composed of 11 plant materials: Radix Sophorae Tonkinensis, Calyx seu Fructus Physalis Francheti, Periostracum Cryptotympanae, Radix Rehmanniae, Fructus Arctii, Radix Scutellariae Baicalensis, Radix Paeoniae Rubra, Semen Oroxyli, Semen Sterculiae Lychnophorae, Cortex Moutan Radicis and Herba Menthae Haplocalycis in a ratio of 1.7:1.7:1.7:2.4:1.7:1.7:2:1.7:1.7:1.7:1.7 (by dry weight). All plant materials were chosen according to the Pharmacopoeia of the People’s Republic of China (2010). Yanshu (2 kg) was prepared as a mixture of all the above components and extracted twice with distilled water (24 and 20 l) at 100°C for 1.5 h. After filtering, the liquid extract was concentrated with a rotary vacuum evaporator to a concentration of 2.0 g/ml and stored at 4°C.

Diclofenac diethylamine emulsion (Votalin) was purchased from Novartis Pharmaceutical Co. (Beijing, China; batch no. X2347); prostaglandin E2 (PGE2) and cycloxygenase-2 (COX-2) ELISA assay kits were purchased from Shanghai Xitang Biological Technology Co., Ltd. (Shanghai, China; batch nos. 1206122 and 1204251); xylene was purchased from Tianda Chemical Factory (Tianjin, China); and λ-carrageenan was purchased from Sigma-Aldrich (Shanghai, China; batch no. 1408463V).

Animals

Mice weighing 18–22 g and male Wistar rats weighing 160–200 g were purchased from the Experimental Animal Center of Shandong Luye Pharmaceutical Co., Ltd. All experimental procedures carried out in this study were performed in accordance with the guidelines for the care and use of laboratory animals of Yantai University, and were approved by the Ethics Committee. All the animals were housed in diurnal lighting conditions (12/12 h) and allowed free access to food and water.

Xylene-induced ear edema model

Forty Swiss mice were randomly divided into control, Votalin and two Yanshu groups (40 and 80 μl doses), each containing 10 animals. Both ears of each mouse were smeared with saline, 50 mg Votalin, 40 μl Yanshu (Yanshu 40) or 80 μl Yanshu (40 μl twice at intervals of 30 min; Yanshu 80). Xylene (20 μl) was dropped onto the anterior and posterior surfaces of the right ear 30 min after the final administration. The mice were sacrificed 1 h after the application of xylene. An ear disc of 9.0-mm diameter was punched out of each ear and weighed. The level of edema was determined from the weight difference between the right (treated) and the left (control) ear discs of the same animal. The inhibition level (%) was calculated according to the following equation: Inhibition (%) = (1−Et/Ec) × 100, where Et is the average edema of the treated group and Ec is the average edema of the saline-treated control group.

Carrageenan-induced paw edema model

Forty Wistar rats were randomly divided into control, Votalin, Yanshu 200 μl (100 μl twice at intervals of 15 min; Yanshu 200) and Yanshu 400 μl (100 μl 4 times at intervals of 15 min; Yanshu 400) groups. The right-hind paw of each rat was then smeared with saline, Votalin or Yanshu. Carrageenan (0.1 ml, 1%w/v) was injected into the right-hind paw (sub-plantar) 30 min after the final administration. The paw volume was measured prior to the irritant injection and at selected intervals (0.5, 1, 1.5, 2, 2.5, 3, 4 and 5 h) thereafter with a hydro-plethysmometer (Shandong Academy of Medical Sciences, Shandong, China). Results were expressed according to the increase in paw volume (ml) calculated by subtracting the basal volume.

Hematoxylin and eosin (H&E) staining

Three hours after carrageenan injection, the rats were anesthetized with chloral hydrate and tissues of the right-hind paw were excised and immersed into 4% formaldehyde for 24 h. The tissues were then embedded in paraffin, sectioned (5 μm) using a microtome and stained with H&E. The pathological features were determined by analysis under a microscope (magnification, x400; Olympus BX41, Tokyo, Japan).

PGE2 and COX-2 assay

Three hours after carrageenan injection, the rats were anesthetized with chloral hydrate and tissues of the right-hind paw were separated on ice and homogenized with ice-cold saline to form a 10% (w/v) homogenate. The levels of PGE2 and COX-2 in the paw were determined using an ELISA kit.

Statistical analysis

The data are expressed as mean ± SD. Data was analyzed using one-way ANOVA with Bonferroni post hoc test for multiple t-tests. P<0.05 was considered to indicate a statistically significant result.

Results

Effects of Yanshu on xylene-induced ear edema in mice

The treatment of the mice with Yanshu 80 but not Yanshu 40 suppressed xylene-induced ear edema significantly, reducing swelling by 34.7% compared with the control group. Votalin administration decreased swelling by 37.3% 1 h after the induction of ear edema (Fig. 1).

Figure 1

Effect of Yanshu on xylene-induced ear edema in mice. Results are expressed as mean ± SD (n=10). *P<0.05 compared with the control group.

Effects of Yanshu on carrageenan-induced paw edema in rats

The treatment of rats with Yanshu 400 but not Yanshu 200 significantly inhibited the development of paw edema at 2 h (P<0.01) and 2.5 h (P<0.05) after carrageenan injection. Votalin also significantly decreased the carrageenan-induced paw edema at 2 h (P<0.01) and 2.5 h (P<0.01) after carrageenan injection (Fig. 2).

Figure 2

Effect of Yanshu on carrageenan-induced paw edema in rats. Results are expressed as mean ± SD (n=10). *P<0.05, **P<0.01 compared with the control group.

Effects of Yanshu on histological pathology of the paws in rats

A large number of inflammatory cells were observed in the paw tissue 3 h after carrageenan injection and the number of neutrophils increased significantly (Fig. 3A and B). Compared with the control group, Votalin and Yanshu treatment, particularly at the higher dose, reduced the number of inflammatory cells significantly (Fig. 3C, D, G and H).

Figure 3

Histopathology of the swollen paw induced by carrageenan in rats. Light photomicrographs of the hematoxylin and eosin stained paw tissue in the (A and B) control, (C and D) Votalin, (E and F) Yanshu 200 and (G and H) Yanshu 400 groups. Arrows indicate the area examined with a high power microscope. Scale bar: A, C, E and G, 200 μm; B, D, F and H, 40 μm.

Effects of Yanshu on the PGE2 levels of the paws in rats

The PGE2 level increased significantly in the paw tissue 3 h after carrageenan injection. Votalin and Yanshu 400 decreased the PGE2 level significantly 3 h after carrageenan injection (P<0.01 and P<0.05, respectively; Fig. 4).

Figure 4

Effect of Yanshu on PGE2 production in the paw tissue of rats induced by carrageenan. Results are expressed as mean ± SD (n=10). *P<0.05, **P<0.01 compared with the control group. PGE2, prostaglandin E2.

Effects of Yanshu on COX-2 level of the paws in rats

The COX-2 level increased significantly in the paw tissue 3 h after carrageenan injection. Votalin and Yanshu 400 decreased the COX-2 level significantly 3 h after carrageenan injection (P<0.01 and P<0.05, respectively; Fig. 5).

Figure 5

Effect of Yanshu on the COX-2 production in paw tissues of rats induced by carrageenan. Results are expressed as mean ± SD (n=10). *P<0.05, **P<0.01 compared with the control group. COX-2, cyclooxygenase-2.

Discussion

In the present study, we examined the in vivo anti-inflammatory effect of Yanshu using two common animal models of inflammation, xylene-induced ear edema in mice and carrageenan-induced paw edema in rats. In addition, the histopathology and inflammatory mediators, including PGE2 and COX-2, were determined to illuminate the underlying anti-inflammatory mechanisms of action.

Xylene-induced ear edema in mice is a simple animal model for evaluating potential anti-inflammatory agents (8,9). In our study, xylene-induced ear edema led to fluid accumulation and edema, characteristic of the acute inflammatory response. Treatment of the mice with Votalin and a high dose of Yanshu suppressed xylene-induced ear edema, reducing swelling by 37.3 and 34.7%, respectively. The data indicate that Yanshu possesses inhibitory effects against acute inflammation.

Carrageenan-induced paw edema is another model which is widely employed for screening the effects of anti-inflammatory drugs (10,11). The acute inflammatory response induced by carrageenan injection involves two phases (12). The early phase occurs during the first hour of exposure and is associated with the release of histamine, serotonin, bradykinin and, to a lesser extent, prostaglandins (PGs). The delayed phase after one hour is attributed to polymorphonuclear (PMN) leucocyte infiltration and the continuation of PG generation. In the present study, a large number of inflammatory cells were observed in the paw tissue 3 h after carrageenan injection and the number of neutrophils increased significantly. Compared with the control group, Votalin and Yanshu treatment, particularly the higher dose, reduced the number of inflammatory cells significantly. These data support the results from the ear edema assay and verify the anti-inflammatory effect of Yanshu against acute inflammation.

It is well established that PGs, by virtue of their activity as modulators of inflammatory responses, have a major role in the inflammatory process. COX is the key enzyme that synthesizes PGs and thromboxane from arachidonic acid. Inappropriate COX-2 expression is known to be involved in the development of inflammatory pathogenesis seen in diseases of the gastrointestinal tract and central nervous system, ischemia and lung inflammation and fibrosis (13,14). In the present study, treatment with Yanshu significantly inhibited the paw edema 2–2.5 h after carrageenan injection. In addition, Yanshu also decreased the production of PGE2 and COX-2 in the hind paws of carrageenan-treated rats; this indicated that Yanshu exerted an anti-inflammatory effect by inhibiting the PGE2/COX-2 inflammatory pathway.

In conclusion, the present study demonstrated that Yanshu possesses anti-inflammatory activities that may be mediated through the regulation of the PGE2/COX-2 inflammatory pathway. These findings indicate that Yanshu may be of benefit for the treatment of acute pharyngitis in the clinic.

Acknowledgements

This study was supported by the 11th Five Years Key Programs for Science and Technology Development of China (grant no. 2010ZX09102-207) and Taishan Scholar Project. The authors are grateful to Professor Tongshen Liu for providing technical assistance in pathological observation.

References

1 

Bisno AL: Acute pharyngitis. N Engl J Med. 344:205–211. 2001. View Article : Google Scholar : PubMed/NCBI

2 

Shah R, Bansal A and Singhi SC: Approach to a child with sore throat. Indian J Pediatr. 78:1268–1272. 2011. View Article : Google Scholar : PubMed/NCBI

3 

Schams SC and Goldman RD: Steroids as adjuvant treatment of sore throat in acute bacterial pharyngitis. Can Fam Physician. 58:52–54. 2012.PubMed/NCBI

4 

Tasar A, Yanturali S, Topacoglu H, Ersoy G, Unverir P and Sarikaya S: Clinical efficacy of dexamethasone for acute exudative pharyngitis. J Emerg Med. 35:363–367. 2008. View Article : Google Scholar : PubMed/NCBI

5 

Mullarkey C: Soothing a sore throat: the efficacy and safety of steroids in acute pharyngitis. Ir J Med Sci. 180:837–840. 2011. View Article : Google Scholar : PubMed/NCBI

6 

Huang Y, Wu T, Zeng L and Li S: Chinese medicinal herbs for sore throat. Cochrane Database Syst Rev. 3:CD0048772012.

7 

Sun Y, Zang Z, Xu X, Zhang Z, Zhong L, Zan W, Zhao Y and Sun L: Experimental investigation of the immunoregulatory and anti-inflammatory effects of the traditional Chinese medicine ‘Li-Yan Zhi-Ke Granule’ for relieving chronic pharyngitis in rats. Mol Biol Rep. 38:199–203. 2011.PubMed/NCBI

8 

Zhang Z, Luo P, Li J, Yi T, Wang J, An J and Zhang H: Comparison of the antiinflammatory activities of three medicinal plants known as ‘meiduoluomi’ in Tibetan folk medicine. Yakugaku Zasshi. 128:805–810. 2008.

9 

Wang D, Wang S, Chen X, Xu X, Zhu J, Nie L and Long X: Antitussive, expectorant and anti-inflammatory activities of four alkaloids isolated from Bulbus of Fritillaria wabuensis. J Ethnopharmacol. 139:189–193. 2012. View Article : Google Scholar : PubMed/NCBI

10 

Li YC, Xian YF, Ip SP, et al: Anti-inflammatory activity of patchouli alcohol isolated from Pogostemonis Herba in animal models. Fitoterapia. 82:1295–1301. 2011. View Article : Google Scholar : PubMed/NCBI

11 

Niu X, Xing W, Li W, Fan T, Hu H and Li Y: Isofraxidin exhibited anti-inflammatory effects in vivo and inhibited TNF-α production in LPS-induced mouse peritoneal macrophages in vitro via the MAPK pathway. Int Immunopharmacol. 14:164–171. 2012.PubMed/NCBI

12 

Gilligan JP, Lovato SJ, Erion MD and Jeng AY: Modulation of carrageenan-induced hind paw edema by substance P. Inflammation. 18:285–292. 1994. View Article : Google Scholar : PubMed/NCBI

13 

Botting J: Defining the role of COX-2 inhibitors in inflammatory and other diseases. Drug News Perspect. 13:560–566. 2000. View Article : Google Scholar : PubMed/NCBI

14 

Minghetti L: Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseases. J Neuropathol Exp Neurol. 63:901–910. 2004.PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhang J, Wang H, Wang T, Chong Y, Yu P, Lu C, Xue Y, Fu F and Zhang L: Anti-inflammatory activity of Yanshu spraying agent in animal models. Exp Ther Med 5: 73-76, 2013.
APA
Zhang, J., Wang, H., Wang, T., Chong, Y., Yu, P., Lu, C. ... Zhang, L. (2013). Anti-inflammatory activity of Yanshu spraying agent in animal models. Experimental and Therapeutic Medicine, 5, 73-76. https://doi.org/10.3892/etm.2012.761
MLA
Zhang, J., Wang, H., Wang, T., Chong, Y., Yu, P., Lu, C., Xue, Y., Fu, F., Zhang, L."Anti-inflammatory activity of Yanshu spraying agent in animal models". Experimental and Therapeutic Medicine 5.1 (2013): 73-76.
Chicago
Zhang, J., Wang, H., Wang, T., Chong, Y., Yu, P., Lu, C., Xue, Y., Fu, F., Zhang, L."Anti-inflammatory activity of Yanshu spraying agent in animal models". Experimental and Therapeutic Medicine 5, no. 1 (2013): 73-76. https://doi.org/10.3892/etm.2012.761
Copy and paste a formatted citation
x
Spandidos Publications style
Zhang J, Wang H, Wang T, Chong Y, Yu P, Lu C, Xue Y, Fu F and Zhang L: Anti-inflammatory activity of Yanshu spraying agent in animal models. Exp Ther Med 5: 73-76, 2013.
APA
Zhang, J., Wang, H., Wang, T., Chong, Y., Yu, P., Lu, C. ... Zhang, L. (2013). Anti-inflammatory activity of Yanshu spraying agent in animal models. Experimental and Therapeutic Medicine, 5, 73-76. https://doi.org/10.3892/etm.2012.761
MLA
Zhang, J., Wang, H., Wang, T., Chong, Y., Yu, P., Lu, C., Xue, Y., Fu, F., Zhang, L."Anti-inflammatory activity of Yanshu spraying agent in animal models". Experimental and Therapeutic Medicine 5.1 (2013): 73-76.
Chicago
Zhang, J., Wang, H., Wang, T., Chong, Y., Yu, P., Lu, C., Xue, Y., Fu, F., Zhang, L."Anti-inflammatory activity of Yanshu spraying agent in animal models". Experimental and Therapeutic Medicine 5, no. 1 (2013): 73-76. https://doi.org/10.3892/etm.2012.761
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team